DANIEL M JUNIUS
CIK 1094159 · Chief Executive Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.00M
Companies
4
Total Filings
125
Lifetime Open-Market Net
-$12.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IDXX | Director | 3,561 | $560.88 | $2.00M | -$8.93M | 60 | 2026-05-14 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 98,459 | $15.70 | $1.55M | $214.1K | 17 | 2024-05-01 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 209,987 | $31.23 | $6.56M | -$3.40M | 46 | 2018-03-16 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 2 | 2016-10-25 |
Recent Filings · Page 8 of 13
125 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-13 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-31 | IDXX | Grant (A) | +48 | $5.0K | EDGAR |
| 2016-10-25 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Disp (D) | — | $0 | EDGAR |
| 2016-08-02 | IDXX | Grant (A) | +53 | $5.0K | EDGAR |
| 2016-07-27 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-02 | ImmunoGen, Inc. (IMGN) Delisted | Exer (M) | +27,085 | $86.4K | EDGAR |
| 2016-05-19 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-06 | IDXX | Grant (A) | — | $0 | EDGAR |
| 2016-05-03 | IDXX | Grant (A) | +59 | $5.0K | EDGAR |
| 2016-03-21 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.